The total human evidence base, as of this writing, consists of the following: 1) a Phase I safety trial of 42 healthy volunteers that was registered in 2015, canceled in 2016, and never published, 2) a retrospective case series of 12 patients with knee pain, no control group, and no validated outcome measure, and 3) a 2025 pilot safety study involving two healthy adults who received intravenous infusions at a single private clinic in Florida
The pancreatic beta cells need time to calibrate their insulin response to the new signaling pattern
It is the dose that supports meaningful progress while allowing the patient to eat, hydrate, function, preserve muscle, and maintain follow-up
For L6-GLUT4myc cells, differentiation was initiated at 8090% confluence using -MEM supplemented with 2% horse serum (HS), refreshed every 23 days